Search

Your search keyword '"Zuin S"' showing total 2 results
Start Over Author "Zuin S" Topic betacoronavirus
2 results on '"Zuin S"'

1. Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity.

Author

Padoan A, Zuin S, Cosma C, Basso D, Plebani M, and Bonfante F

Subjects
COVID-19, Coronavirus Infections diagnosis, Enzyme-Linked Immunosorbent Assay methods, Enzyme-Linked Immunosorbent Assay standards, Humans, Neutralization Tests methods, Pandemics, Pneumonia, Viral diagnosis, SARS-CoV-2, Time Factors, Antibodies, Neutralizing blood, Antibodies, Viral blood, Betacoronavirus isolation & purification, Coronavirus Infections blood, Neutralization Tests standards, Pneumonia, Viral blood
Abstract

Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Published
2020
Full Text
View/download PDF

2. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study.

Author

Padoan A, Sciacovelli L, Basso D, Negrini D, Zuin S, Cosma C, Faggian D, Matricardi P, and Plebani M

Subjects
Adult, Aged, Aged, 80 and over, COVID-19, Female, Humans, Longitudinal Studies, Luminescent Measurements methods, Male, Middle Aged, Pandemics, Real-Time Polymerase Chain Reaction methods, SARS-CoV-2, Young Adult, Antibodies, Viral blood, Betacoronavirus isolation & purification, Coronavirus Infections blood, Coronavirus Infections diagnosis, Glycoproteins blood, Immunoglobulin A blood, Pneumonia, Viral blood, Pneumonia, Viral diagnosis
Abstract

Validation studies of serological antibody tests must be properly designed for clinical, epidemiological and Public Health objectives such as confirmation of suspected COVID-19 cases, certification of seroconversion after infection, and epidemiological surveillance. We evaluated the kinetics of IgM, IgA and IgG SARS-CoV-2 antibodies in COVID-19 patients with confirmed (rRT-PCR) infection. We found that the IgA response appears and grows early, peaks at week 3, and it is stronger and more persistent than the IgM response. Further longitudinal investigations of virus-specific antibodies functions and of their protective efficacy over time are needed., (Copyright © 2020 Elsevier B.V. All rights reserved.)

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results